Drug Shortage Report for ACT METHYLPHENIDATE ER

Last updated on 2020-03-05 History
Report ID 65996
Drug Identification Number 02441950
Brand name ACT METHYLPHENIDATE ER
Common or Proper name METHYLPHENIDATE
Company Name ACTAVIS PHARMA COMPANY
Active Ingredient(s) METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 36MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-12-01
Actual start date 2018-12-01
Estimated end date 2020-04-30
Actual end date
Shortage status Actual shortage
Updated date 2020-03-05
Company comments Inventory will be managed and allocated for 100% of regular demand. Estimated run out will be late February.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-12-04 English Compare
v3 2018-12-02 English Compare
v2 2018-11-01 French Compare
v1 2018-11-01 English Compare

Showing 21 to 24 of 24